RxDoctor Payments Data

Gina Caprara

Family · Denver, CONPI 1265965982

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 354 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by AbbVie at 27.4% of the total. Reporting peaked in 2021 at $2,726 and has fallen 67.7% since, to $879 in 2023. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,867in general payments, 2019–2025

Across 354 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$736
  • Lilly USA, LLC$399
  • AstraZeneca$255
  • Eisai Inc.$235
  • Biohaven Pharmaceutical Holding Company Ltd.$181
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,867100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,867 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado →

Other family in Denver

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →